Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction
- PMID: 33648672
- DOI: 10.1016/bs.irn.2020.09.002
Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction
Abstract
Across centuries and civilizations opioids have been used to relieve pain. In our modern societies, opioid-based analgesics remain one of the most efficient treatments for acute pain. However, the long-term use of opioids can lead to the development of analgesic tolerance, opioid-induced hyperalgesia, opioid use disorders, and overdose, which can ultimately produce respiratory depressant effects with fatal consequences. In addition to the nociceptive sensory component of pain, negative affective states arising from persistent pain represent a risk factor for developing an opioid use disorder. Several studies have indicated that the increase in prescribed opioid analgesics since the 1990s represents the root of our current opioid epidemic. In this review, we will present our current knowledge on the endogenous opioid system within the pain neuroaxis and the plastic changes occurring in this system that may underlie the occurrence of pain-induced negative affect leading to misuse and abuse of opioid medications. Dissecting the allostatic neuronal changes occurring during pain is the most promising avenue to uncover novel targets for the development of safer pain medications. We will discuss this along with current and potential approaches to treat pain-induced negative affective states that lead to drug misuse. Moreover, this chapter will provide a discussion on potential avenues to reduce the abuse potential of new analgesic drugs and highlight a basis for future research and drug development based on recent advances in this field.
Keywords: Addiction; Analgesia; Negative affect; Opioid use disorders; Opioids; Pain.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.Curr Pain Headache Rep. 2018 Aug 27;22(11):73. doi: 10.1007/s11916-018-0728-y. Curr Pain Headache Rep. 2018. PMID: 30151792 Review.
-
Tamper-resistant opioid formulations in the treatment of acute pain.Adv Ther. 2014 Mar;31(3):264-75. doi: 10.1007/s12325-014-0099-7. Epub 2014 Feb 14. Adv Ther. 2014. PMID: 24526323 Review.
-
Replacement of current opioid drugs focusing on MOR-related strategies.Pharmacol Ther. 2020 Jun;210:107519. doi: 10.1016/j.pharmthera.2020.107519. Epub 2020 Mar 9. Pharmacol Ther. 2020. PMID: 32165137 Review.
-
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.Otolaryngol Head Neck Surg. 2021 Apr;164(2_suppl):S1-S42. doi: 10.1177/0194599821996297. Otolaryngol Head Neck Surg. 2021. PMID: 33822668
-
Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.Pain Pract. 2019 Apr;19(4):443-454. doi: 10.1111/papr.12760. Epub 2019 Feb 28. Pain Pract. 2019. PMID: 30597739 Free PMC article. Review.
Cited by
-
A Randomized, Double-Blind, Placebo-Controlled Trial Protocol Using the Fuzhengxiaoliu Patch for the Management of Primary Liver Cancer Pain.J Pain Res. 2025 Jan 6;18:33-42. doi: 10.2147/JPR.S500305. eCollection 2025. J Pain Res. 2025. PMID: 39802415 Free PMC article.
-
Endogenous opioid systems alterations in pain and opioid use disorder.Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022. Front Syst Neurosci. 2022. PMID: 36341476 Free PMC article. Review.
-
Treatment of Moderate-to-Severe Pain in Hepatocellular Carcinoma with Transcutaneous Electrical Acupoint Stimulation: A Randomized Controlled Trial.J Pain Res. 2024 Apr 29;17:1583-1594. doi: 10.2147/JPR.S456874. eCollection 2024. J Pain Res. 2024. PMID: 38707266 Free PMC article. Clinical Trial.
-
Estradiol protects against pain-facilitated fentanyl use via suppression of opioid-evoked dopamine activity in males.Neuron. 2025 May 7;113(9):1413-1429.e5. doi: 10.1016/j.neuron.2025.02.013. Epub 2025 Mar 10. Neuron. 2025. PMID: 40068677
-
Cell-type specific molecular architecture for mu opioid receptor function in pain and addiction circuits.Neuropharmacology. 2023 Nov 1;238:109597. doi: 10.1016/j.neuropharm.2023.109597. Epub 2023 Jun 2. Neuropharmacology. 2023. PMID: 37271281 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical